Suchergebnisse - "Specchia, Giorgina"

PubPharm (4)

1

Additional chromosomal abnormalities in Philadelphia-positive clone : adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

enthalten in: Blood | 2012

von Luatti, S. | Castagnetti, F. | Marzocchi, G. | +24

ErratumIn: Blood. 2013 Jun 27;121(26):5259 Cambrin, Rege [corrected to Rege-Cambrin, Giovanna]

2

Variant Philadelphia translocations : molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis

enthalten in: Blood | 2011

von Marzocchi, G. | Castagnetti, F. | Luatti, S. | +23

CommentIn: Blood. 2011 Jun 23;117(25):6741-2. - PMID 21700778

3

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia : a European LeukemiaNet Study

enthalten in: Blood | 2009

von Baccarani, M. | Rosti, G. | Castagnetti, F. | +22

4

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase : a phase 2 trial of the GIMEMA CML Working Party

enthalten in: Blood | 2009

von Castagnetti, F. | Palandri, F. | Amabile, M. | +54

1
[1]